First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab

作者：Xu‐Han Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, Jinquan Wang, Changcheng Zheng · 发表于：Blood Advances · 年份：2020 · DOI：10.1182/bloodadvances.2020001907 · 被引用次数：257 · 研究领域：Multiple Myeloma Research and Treatments、SARS-CoV-2 and COVID-19 Research、COVID-19 Clinical Research Studies

Key Points We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.